Cite Filings / DFTX / 0000950170-22-009955

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Definium Therapeutics, Inc. Filed 2022-05-16 Acc 0000950170-22-009955

Documents 1

10-Q Quarterly Report , mnmd-20220331.htm

Around this filing

2022-08-11 10-Q Quarterly Report
2022-05-19 4/A Chief Executive Officer sold 18,948 shares at $0.71 ($13,453)
2022-05-17 4 Chief Executive Officer gave up 18,948 shares (to pay taxes)
2022-05-16 EFFECT Notice of Effectiveness
2022-05-16 10-Q Quarterly Report
2022-05-16 8-K Results of operations
2022-05-13 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading mnmd-20220331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…